Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek, M J, Schluger, J, Borg, L, Gunduz, M, Ho, aVolume:
288
Year:
1999
Language:
english
Journal:
The Journal of pharmacology and experimental therapeutics
DOI:
10.0000/PMID9862779
File:
PDF, 176 KB
english, 1999